Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinhuang Diwan for recurrent oral ulcer
CTR20231007Phase 2Completed
- Sponsor
- Zhejiang Wecome Pharmaceutical
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yinhuang diwan in aphthosis (RAS), sponsored by Zhejiang Wecome Pharmaceutical. Started Apr 2023; status: completed.
02
Drugs
yinhuang diwan
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on CTR20231007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231007.